Search for: "Otsuka Pharmaceutical Co., Ltd." Results 21 - 37 of 37
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Jun 2012, 12:31 am by Mark Summerfield
Generic Health Pty Ltd v Otsuka Pharmaceutical Co Ltd [2012] FCA 412 (23 April 2012) Practice and procedure – interlocutory injunction – whether application for leave to appeal should be referred to a Full Court Generic Health Pty Ltd will have the opportunity to appeal the decision of a single judge of the Federal Court of Australia granting a preliminary injunction preventing it from launching a generic version of the… [read post]
7 May 2012, 10:51 am by Rantanen
By Jason Rantanen Otsuka Pharmaceutical Co., Ltd. v. [read post]
28 Mar 2012, 1:31 am by Mark Summerfield
  This time the drug in question is ‘atypical’ antipsychotic aripiprazole, marketed by Bristol-Meyers Squibb (BMS) as ABILIFY, under license from the patentee Otsuka Pharmaceutical Co., Ltd. [read post]
24 Nov 2010, 12:37 am by Kelly
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
17 Nov 2010, 7:05 pm by Lawrence B. Ebert
DNJ on Monday, Nov. 15 upheld the Abilify patent of Otsuka Pharmaceutical Co. [read post]
16 Jun 2010, 3:02 pm
(Docket Report) US: Re-examination ordered on ‘expired’ Harvard Oncomouse patent (Patent Docs)   Products Abilify (Aripiprazole) – US: Patent infringement complaint following a Paragraph IV certification: Otsuka Pharmaceutical Co., Ltd. v. [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd & Anor (IPKat) (The SPC blog) Sustiva (Efavirenz) - Brazil: Compulsory licensed Efavirenz will be manufactured by public Brazilian laboratories by end of 2008 (IP tango)   General A patent question of patents: Prof T Pogge's 'Health Impact Fund'… [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous system stem cell and… [read post]
14 May 2008, 9:35 pm
Snecama Aerospace Industry (Suzhou) Co., Ltd. and Messier-Dowty Aerospace (Suzhou) Co., Ltd., the two subsidiaries of the French-owned Safran Corporation and manufacturers of components parts of aircraft engines and landing gears, celebrated official opening on April 7 in SIP Suzhou Otsuka Pharmaceutical Co., Ltd., invested by the Japanese-owned Otsuka Pharmaceutical Co, held a foundation laying… [read post]
4 Apr 2008, 1:00 am
- Counterfeit cash flooding the market: (Afro-IP), Debranded fakes for Liberia: an update: (Afro-IP), South African music industry blames pirates for falling sales of local artists: (Afro-IP), Plaintiff obtains interlocutory relief in patent case Sanitam Services Limited v Bins (Nairobi) Services Limited: (Afro-IP), South Africa – new patent judgments: Buckman Laboratories v Bromine Compounds; Northpark Trading 3 (Pty) Ltd v Ausplow (Pty) Ltd: (Afro-IP) … [read post]
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]
19 Dec 2007, 4:04 pm
Singer -- In a December 17, 2007 press release, Otsuka Pharmaceutical Co., Ltd. and PDL BioPharma, Inc. announced a finalized agreement in which Otsuka acquires intellectual property related assets to IV Busulfex ® (busulfan) from PDL. [read post]